Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 37.74
-0.343 %
$ 2.08 B
Market Cap
35.27
P/E
SUPN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities SUPN - Supernus Pharmaceuticals, Inc.
269 M
LAST VALUE
129.80%
2 YEAR CAGR
21.52%
5 YEAR CAGR
37.52%
10 YEAR CAGR